Atlas Trials

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Clinical trial NCT00129961 · COMPLETED

Trial details

NCT number
NCT00129961
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Skin NeoplasmsKidney Transplantation
Start date
2005-08-01
Primary completion
2009-01-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.